企業プロフィール
BriaCell 株価・ニュース・カタリスト
- ティッカー:
- BCTX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Canada
株価パフォーマンス
3.39 USD (-1.45%)
終値
最終更新: 2026年8月17日
23.7M USD
時価総額
株価変動の要因
As of Aug 17, 2026, BCTX closed down 1.45% at $3.39. No new same-company headline was identified in the current news window.
企業概要
事業概要
BriaCell is an immuno-oncology company focused on cancer vaccines and cellular immunotherapy. Its platform aims to create targeted immune responses against tumors.
所在地とセクター分類
Headquartered in Canada and listed on NASDAQ, BriaCell has a cross-border cancer-biotech profile.
ビジネスモデルの特徴
The company depends on clinical data, immunotherapy differentiation, and the ability to create a niche oncology franchise.
バイオ業界での位置付け
BriaCell is a high-beta immunotherapy name whose valuation is highly sensitive to early clinical updates.
今後のカタリスト
- BriaCell’s catalysts are Bria-IMT and its oncology immunotherapy platform, especially any readout that shows the company can keep advancing toward a viable clinical profile. The stock is driven by binary data.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。